9106262|t|Evaluation of human astrocytoma and glioblastoma cell lines for nerve growth factor release.
9106262|a|Nerve growth factor (NGF) prevents degeneration of cholinergic neurons in the central nervous system (CNS), and has potential as a therapeutic treatment for Alzheimer's disease. The inability of NGF to cross the blood-brain barrier has prompted pharmacological approaches investigating peripherally administered compounds that stimulate release of endogenous NGF. This study describes the NGF-releasing properties of six human astrocytoma and glioblastoma cell lines (SW 1088, SW 1783 and CRL 1718 astrocytomas, and U-138, U-373, and T98G glioblastomas). Using a highly specific two-site ELISA for human NGF, basal NGF release could be detected in all cell lines, with the lowest level in the T98G line (approximately 80 pg NGF/ml). Cell lines tested with a variety of compounds for 24 h in serum-free media demonstrated stimulation of NGF release by distinct mechanisms. NGF levels were markedly elevated (up to 8-fold above vehicle-treated cells) when stimulated with the cytokine interleukin-1 beta (IL-1 beta). Phorbol ester stimulated NGF release 4-fold. Clenbuterol, 4-methyl catechol, and propentofylline had little activity, while 6-(4-hydroxybutyl)-2,3,5,-trimethyl-1,4,benzoquinone (TMQ), dexamethasone and 1,25-dihydroxyvitamin D3 elevated NGF levels 3-fold. These data indicate differences in the ability of human astrocytoma and glioblastoma cells to release NGF when stimulated with mechanistically distinct compounds.
9106262	14	19	human	Species	9606
9106262	20	31	astrocytoma	Disease	MESH:D001254
9106262	36	48	glioblastoma	Disease	MESH:D005909
9106262	64	83	nerve growth factor	Gene	4803
9106262	93	112	Nerve growth factor	Gene	4803
9106262	114	117	NGF	Gene	4803
9106262	250	269	Alzheimer's disease	Disease	MESH:D000544
9106262	288	291	NGF	Gene	4803
9106262	452	455	NGF	Gene	4803
9106262	482	485	NGF	Gene	4803
9106262	514	519	human	Species	9606
9106262	520	531	astrocytoma	Disease	MESH:D001254
9106262	536	548	glioblastoma	Disease	MESH:D005909
9106262	561	568	SW 1088	CellLine	CVCL:1715
9106262	570	577	SW 1783	CellLine	CVCL:1722
9106262	582	603	CRL 1718 astrocytomas	CellLine	CVCL:YD58
9106262	609	614	U-138	CellLine	CVCL:0020
9106262	616	621	U-373	CellLine	CVCL:2818
9106262	627	631	T98G	CellLine	CVCL:0556
9106262	632	645	glioblastomas	Disease	MESH:D005909
9106262	691	696	human	Species	9606
9106262	697	700	NGF	Gene	4803
9106262	708	711	NGF	Gene	4803
9106262	786	790	T98G	CellLine	CVCL:0556
9106262	817	820	NGF	Gene	4803
9106262	929	932	NGF	Gene	4803
9106262	965	968	NGF	Gene	4803
9106262	1076	1094	interleukin-1 beta	Gene	3553
9106262	1096	1105	IL-1 beta	Gene	3553
9106262	1108	1121	Phorbol ester	Chemical	MESH:D010703
9106262	1133	1136	NGF	Gene	4803
9106262	1153	1164	Clenbuterol	Chemical	MESH:D002976
9106262	1166	1183	4-methyl catechol	Chemical	MESH:C018599
9106262	1189	1204	propentofylline	Chemical	MESH:C032114
9106262	1232	1284	6-(4-hydroxybutyl)-2,3,5,-trimethyl-1,4,benzoquinone	Chemical	MESH:C086107
9106262	1286	1289	TMQ	Chemical	MESH:C086107
9106262	1292	1305	dexamethasone	Chemical	MESH:D003907
9106262	1310	1334	1,25-dihydroxyvitamin D3	Chemical	MESH:D002117
9106262	1344	1347	NGF	Gene	4803
9106262	1413	1418	human	Species	9606
9106262	1419	1430	astrocytoma	Disease	MESH:D001254
9106262	1435	1447	glioblastoma	Disease	MESH:D005909
9106262	1465	1468	NGF	Gene	4803
9106262	Positive_Correlation	MESH:D002117	4803
9106262	Negative_Correlation	MESH:D000544	4803
9106262	Positive_Correlation	MESH:D010703	4803
9106262	Positive_Correlation	MESH:C086107	4803
9106262	Association	MESH:D005909	4803
9106262	Positive_Correlation	MESH:D003907	4803
9106262	Positive_Correlation	3553	4803
9106262	Association	MESH:D001254	4803

